Stroke in HIV infection and AIDS

References

• Berger JR, Harris JO, Gregorios J, Norenberg M. Cerebrovascular disease in AIDS: a case–control study. AIDS4(3), 239–244 (1990).
   PubMed Web of Science ®Google Scholar
• Gebo KA, Justice A. HIV infection in the elderly. Curr. Infect. Dis. Rep.11(3), 246–254 (2009).
   PubMedGoogle Scholar
• Murray JM, McDonald AM, Law MG. Rapidly ageing HIV epidemic among men who have sex with men in Australia. Sex. Health6(1), 83–86 (2009).
   PubMed Web of Science ®Google Scholar
• Martin CP, Fain MJ, Klotz SA. The older HIV-positive adult: a critical review of the medical literature. Am. J. Med.121(12), 1032–1037 (2008).
   PubMed Web of Science ®Google Scholar
• Hadigan C, JB Meigs, Corcoran C et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin. Infect. Dis.32(1), 130–139 (2001).
   PubMed Web of Science ®Google Scholar
• Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS17(Suppl. 1), S141–S148 (2003).
   PubMed Web of Science ®Google Scholar
• Friis-Moller N, Weber R, Reiss P et al. Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study. AIDS17(8), 1179–1193 (2003).
   PubMed Web of Science ®Google Scholar
• Friis-Moller N, Reiss P, Sabin CA et al. Class of antiretroviral drugs and the risk of myocardial infarction. N. Engl. J. Med.356(17), 1723–1735 (2007).
   PubMed Web of Science ®Google Scholar
• Jerico C, Knobel H, Calvo N et al. Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke37(3), 812–817 (2006).
   PubMed Web of Science ®Google Scholar
• Subsai K, Kanoksri S, Siwaporn C, Helen L, Kanokporn O, Wantana P. Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study. Eur. J. Neurol.13(3), 233–239 (2006).
   PubMed Web of Science ®Google Scholar
• Bardgett HP, Dixon M, Beeching NJ. Increase in hospital mortality from non-communicable disease and HIV-related conditions in Bulawayo, Zimbabwe, between 1992 and 2000. Trop. Doct.36(3), 129–131 (2006).
   Google Scholar
• Pinto AN. AIDS and cerebrovascular disease. Stroke27(3), 538–543 (1996).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Janssen RS, Karon JM et al. Human immunodeficiency virus infection and stroke in young patients. Arch. Neurol.54(9), 1150–1153 (1997).
   PubMedGoogle Scholar
• Evers S, Nabavi D, Rahmann A, Heese C, Reichelt D, Husstedt IW. Ischaemic cerebrovascular events in HIV infection: a cohort study. Cerebrovasc. Dis.15(3), 199–205 (2003).
   PubMed Web of Science ®Google Scholar
• Cole JW, Pinto AN, Hebel JR et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke35(1), 51–56 (2004).
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Berger JR, Nath A, Rayens M. Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J. Neurovirol.6(3), 229–236 (2000).
   PubMed Web of Science ®Google Scholar
• Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A. Stroke in patients with human immunodeficiency virus infection. J. Neurol. Neurosurg. Psychiatry78(12), 1320–1324 (2007).
   PubMed Web of Science ®Google Scholar
• Connor M. Stroke in patients with human immunodeficiency virus infection. J. Neurol. Neurosurg. Psychiatry78(12), 1291 (2007).
   PubMed Web of Science ®Google Scholar
• Ortiz G, Koch S, Romano JG, Forteza AM, Rabinstein AA. Mechanisms of ischemic stroke in HIV-infected patients. Neurology68(16), 1257–1261 (2007).
   PubMed Web of Science ®Google Scholar
• Park YD, Belman AL, Kim TS et al. Stroke in pediatric acquired immunodeficiency syndrome. Ann. Neurol.28(3), 303–311 (1990).
   PubMed Web of Science ®Google Scholar
• Gillams AR, Allen E, Hrieb K, Venna N, Craven D, Carter AP. Cerebral infarction in patients with AIDS. Am. J. Neuroradiol.18(8), 1581–1585 (1997).
   Google Scholar
• Chalazonitis AN, Nomikou E, Condilis N et al. Intracranial hemorrhage in a HIV patient. Case report and review of the literature. Ann. Ital. Chir.78(3), 237–241 (2007).
   Google Scholar
• Antunes SV, Vicari P, Cavalheiro S, Bordin JO. Intracranial haemorrhage among a population of haemophilic patients in Brazil. Haemophilia9(5), 573–577 (2003).
   PubMed Web of Science ®Google Scholar
• Ake JA, Erickson JC, Lowry KJ. Cerebral aneurysmal arteriopathy associated with HIV infection in an adult. Clin. Infect. Dis.43(5), E46–E50 (2006).
   Web of Science ®Google Scholar
• Kim IY, Jung S, Jung TY, Kang SS, Choi C. Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study. Surg. Neurol.70(3), 308–311 (2008).
   Google Scholar
• Berlit P, Popescu O, Weng Y, Malessa R. Disseminated cerebral hemorrhages as unusual manifestation of toxoplasmic encephalitis in AIDS. J. Neurol. Sci.143(1–2), 187–189 (1996).
   Google Scholar
• Roquer J, Palomeras E, Knobel H, Pou A. Intracerebral haemorrhage in AIDS. Cerebrovasc. Dis.8(4), 222–227 (1998).
   PubMed Web of Science ®Google Scholar
• Saif MW, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS15(1), 15–24 (2001).
   PubMed Web of Science ®Google Scholar
• Shen YM, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin. Appl. Thromb. Hemost.10(3), 277–280 (2004).
   Google Scholar
• Sene D, Piette JC, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun. Rev.7(4), 272–277 (2008).
   PubMed Web of Science ®Google Scholar
• Abuaf N, Laperche S, Rajoely B et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb. Haemost.77(5), 856–861 (1997).
   Google Scholar
• Avcin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr. Rheumatol. Rep.9(3), 212–218 (2007).
   Google Scholar
• Rubbert A, Bock E, Schwab J et al. Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. Clin. Exp. Immunol.98(3), 361–368 (1994).
   Google Scholar
• Keeling DM, Birley H, Machin SJ. Multiple transient ischaemic attacks and a mild thrombotic stroke in a HIV-positive patient with anticardiolipin antibodies. Blood Coagul. Fibrinolysis1(3), 333–335 (1990).
   Google Scholar
• Brew BJ, Miller J. Human immunodeficiency virus type 1-related transient neurological deficits. Am. J. Med.101(3), 257–261 (1996).
   PubMed Web of Science ®Google Scholar
• Giordano N, Amendola A, Papakostas P et al. Possible pathogenetic role of antiphospholipid antibodies in a clinical case of human immunodeficiency virus infection with peripheral polyneuropathy and arterial thrombosis. New Microbiol.28(3), 261–263 (2005).
   Google Scholar
• Germano N, Mendonca P, Murinello A. Pulmonary embolism associated to HIV infection. Rev. Port. Pneumol.11(4), 407–412 (2005).
   Google Scholar
• Shahnaz S, Parikh G, Opran A. Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. Am. J. Med. Sci.327(4), 231–232 (2004).
   Google Scholar
• Hassoun A, Al-Kadhimi Z, Cervia J. HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS18(6), 333–340 (2004).
   PubMedGoogle Scholar
• Brown P, Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin. Infect. Dis.32(8), 1221–1226 (2001).
   PubMed Web of Science ®Google Scholar
• Green D, Otoya J, Oriba H, Rovner R. Protein S deficiency in middle-aged women with stroke. Neurology42(5), 1029–1033 (1992).
   PubMed Web of Science ®Google Scholar
• Mayer SA, Sacco RL, Hurlet-Jensen A, Shi T, Mohr JP. Free protein S deficiency in acute ischemic stroke. A case–control study. Stroke24(2), 224–227 (1993).
   Google Scholar
• Restrepo L, Fayad P. Hypercoagulability. Continuum9, 69–82 (2003).
   Google Scholar
• Mochan A, Modi M, Modi G. Stroke in black South African HIV-positive patients: a prospective analysis. Stroke34(1), 10–15 (2003).
   PubMed Web of Science ®Google Scholar
• Mochan A, Modi M, Modi G. Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J. Neurol. Neurosurg. Psychiatry76(10), 1455–1456 (2005).
   PubMed Web of Science ®Google Scholar
• Rodriguez GJ, Cordina SM, Vazquez G et al. The hydration influence on the risk of stroke (THIRST) study. Neurocrit. Care10(2), 187–194 (2009).
   Google Scholar
• deMarinis M, Arnett EN. Cerebrovascular occlusion in a transsexual man taking mestranol. Arch. Intern. Med.138(11), 1732–1733 (1978).
   PubMedGoogle Scholar
• Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertil. Steril.OI: 10.1016/j.fertnstert.2008.12.017 (2009) (Epub ahead of print).
   Google Scholar
• Martin CM, Matlow AG, Chew E, Sutton D, Pruzanski W. Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch. Intern. Med.149(6), 1435–1436 (1989).
   Google Scholar
• Paul B, Houston S, Latif AS. HIV infection associated with the plasma hyperviscosity syndrome: a report of two fatal cases. AIDS4(12), 1302–1304 (1990).
   Google Scholar
• Garderet L, Fabiani B, Lacombe K, Girard PM, Flejou JF, Gorin NC. Hyperviscosity syndrome in an HIV-1-positive patient. Am. J. Med.117(11), 891–893 (2004).
   Google Scholar
• Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin. Thromb. Hemost.29(5), 451–458 (2003).
   PubMed Web of Science ®Google Scholar
• Cerrato P, Grasso M, Imperiale D et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc. Dis.18(2), 154–159 (2004).
   PubMed Web of Science ®Google Scholar
• Roldan EO, Moskowitz L, Hensley GT. Pathology of the heart in acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med.111(10), 943–946 (1987).
   PubMed Web of Science ®Google Scholar
• Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann. Neurol.14(4), 403–418 (1983).
   PubMed Web of Science ®Google Scholar
• Levy RM, Bredesen DE. Central nervous system dysfunction in acquired immunodeficiency syndrome. J. Acquir. Immune Defic. Syndr.1(1), 41–64 (1988).
   PubMed Web of Science ®Google Scholar
• Engstrom JW, Lowenstein DH, Bredesen DE. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am. J. Med.86(5), 528–532 (1989).
   PubMed Web of Science ®Google Scholar
• Mesquita ET, Ramos RG, Ferrari AH, Martins Wde A, da Cruz GG. [Rheumatic heart disease and infective endocarditis in a patient with acquired immunodeficiency syndrome. Arq. Bras. Cardiol.67(4), 255–257 (1996).
   Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc.59(1), 17–20 (1984).
   PubMed Web of Science ®Google Scholar
• Schifitto G, Holloway R. Cerebrovascular disease in patients with HIV-1 associated pulmonary hypertension. J. NeuroAIDS2(2), 57–64 (1999).
   PubMedGoogle Scholar
• Kieburtz KD, Eskin TA, Ketonen L, Tuite MJ. Opportunistic cerebral vasculopathy and stroke in patients with the acquired immunodeficiency syndrome. Arch. Neurol.50(4), 430–432 (1993).
   PubMed Web of Science ®Google Scholar
• Eidelberg D, Sotrel A, Horoupian DS, Neumann PE, Pumarola-Sune T, Price RW. Thrombotic cerebral vasculopathy associated with herpes zoster. Ann. Neurol.19(1), 7–14 (1986).
   PubMed Web of Science ®Google Scholar
• Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N. Engl. J. Med.316(25), 1569–1572 (1987).
   PubMed Web of Science ®Google Scholar
• Kase CS, Levitz SM, Wolinsky JS, Sulis CA. Pontine pure motor hemiparesis due to meningovascular syphilis in human immunodeficiency virus-positive patients. Arch. Neurol.45(8), 832 (1988).
   PubMedGoogle Scholar
• Berger JR. Neurosyphilis. In: Neurology Medlink. Gilman SA (Ed.). Arbor Publications, CA, USA (2009).
   Google Scholar
• Hook EJ. Syphilis in Infections of the Central Nervous System. Scheld WM, Whitley RJ, Durack DT (Eds). Lippincott-Raven, PA, USA, 669–684 (1997).
   Google Scholar
• Nagel MA, Cohrs RJ, Mahalingam R et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology70(11), 853–860 (2008).
   PubMed Web of Science ®Google Scholar
• Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LE, Gilden DH. The vasculopathy of varicella-zoster virus encephalitis. Ann. Neurol.37(6), 784–790 (1995).
   PubMedGoogle Scholar
• Gilden DH, Mahalingam R, Cohrs RJ, Kleinschmidt-DeMasters BK, Forghani B. The protean manifestations of varicella-zoster virus vasculopathy. J. Neurovirol.8(Suppl. 2), 75–79 (2002).
   PubMed Web of Science ®Google Scholar
• Gray F, Belec L, Lescs MC et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain117(Pt 5), 987–999 (1994).
   PubMed Web of Science ®Google Scholar
• Frank Y, Lu D, Pavlakis S, Black K, LaRussa P, Hyman RA. Childhood AIDS, varicella zoster, and cerebral vasculopathy. J. Child Neurol.12(7), 464–466 (1997).
   Google Scholar
• Nogueras C, Sala M, Sasal M et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch. Neurol.59(3), 468–473 (2002).
   Google Scholar
• Melica G, Brugieres P, Lascaux AS, Levy Y, Lelievre JD. Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J. Med. Virol.81(4), 578–581 (2009).
   Google Scholar
• Cornely OA, Hauschild S, Weise C et al. Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection. Infection27(2), 92–96 (1999).
   Google Scholar
• Jansen TL, van Houte D, de Vries T, Wolthuis A. ANCA seropositivity in HIV: a serological pitfall. Neth. J. Med.63(7), 270–274 (2005).
   Google Scholar
• Winslow BT, Voorhees KI, Pehl KA. Methamphetamine abuse. Am. Fam. Physician76(8), 1169–1174 (2007).
   PubMed Web of Science ®Google Scholar
• Seaman ME. Acute cocaine abuse associated with cerebral infarction. Ann. Emerg. Med.19(1), 34–37 (1990).
   Google Scholar
• Diez-Tejedor E, Frank A, Gutierrez M, Barreiro P. Encephalopathy and biopsy-proven cerebrovascular inflammatory changes in a cocaine abuser. Eur. J. Neurol.5(1), 103–107 (1998).
   PubMed Web of Science ®Google Scholar
• Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology46(5), 1291–1296 (1996).
   Google Scholar
• Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology46(6), 1741–1743 (1996).
   Google Scholar
• Ohta K, Mori M, Yoritaka A, Okamoto K, Kishida S. Delayed ischemic stroke associated with methamphetamine use. J. Emerg. Med.28(2), 165–167 (2005).
   PubMed Web of Science ®Google Scholar
• Miller MA, Coon TP. Re: Delayed ischemic stroke associated with methamphetamine use. J. Emerg. Med.31(3), 305–306, author reply 306 (2006).
   Google Scholar
• Connor MD, Lammie GA, Bell JE, Warlow CP, Simmonds P, Brettle RD. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke31(9), 2117–2126 (2000).
   PubMed Web of Science ®Google Scholar
• Mizusawa H, Hirano A, Llena JF, Shintaku M. Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol.76(5), 451–457 (1988).
   PubMed Web of Science ®Google Scholar
• Tipping B, de Villiers L, Candy S, Wainwright H. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch. Neurol.63(11), 1640–1642 (2006).
   PubMedGoogle Scholar
• Tran Dinh YR, Mamo H, Cervoni J, Caulin C, Saimot AC. Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J. Nucl. Med.31(10), 1601–1607 (1990).
   PubMed Web of Science ®Google Scholar
• Brilla R, Nabavi DG, Schulte-Altedorneburg G et al. Cerebral vasculopathy in HIV infection revealed by transcranial Doppler: a pilot study. Stroke30(4), 811–813 (1999).
   PubMed Web of Science ®Google Scholar
• Maggi P, Serio G, Epifani G et al. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS14(16), F123–F128 (2000).
   PubMed Web of Science ®Google Scholar
• Depairon M, Chessex S, Sudre P et al. Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy. AIDS15(3), 329–334 (2001).
   PubMed Web of Science ®Google Scholar
• Hsue PY, Lo JC, Franklin A et al. Progression of atherosclerosis as assessed by carotid intima–media thickness in patients with HIV infection. Circulation109(13), 1603–1608 (2004).
   PubMed Web of Science ®Google Scholar
• Oliviero U, Bonadies G, Apuzzi V et al. Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis204(2), 586–589 (2008).
   Google Scholar
• Francisci D, Giannini S, Baldelli F et al. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction. AIDS23(5), 589–596 (2009).
   PubMed Web of Science ®Google Scholar
• Barbaro G, Iacobellis G. Metabolic syndrome associated with HIV and highly active antiretroviral therapy. Curr. Diab. Rep.9(1), 37–42 (2009).
   PubMed Web of Science ®Google Scholar
• Zou W, Berglund L. HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk. Prev. Cardiol.10(2), 96–103; quiz 104–105 (2007).
   PubMedGoogle Scholar